スライド2.PNG.png

アプリ案内

General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Wed. Dec 3, 2025

Thu. Dec 4, 2025

Fri. Dec 5, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Use of the AI Simultaneous Interpretation System

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Please enter the password printed on your name card.<br>Online registrants can download your name card from the account page once payment has been successfully processed.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

PMR-116, a second generation ribosome biogenesis inhibitor

Post-transcriptional regulation, including mRNA translation and degradation, has long been considered essential for maintaining cellular homeostasis. However, recent technological advances have challenged conventional views, uncovering novel RNA regulatory mechanisms that play crucial roles in biological processes and disease pathogenesis. The selective translation and degradation of specific mRNAs, as well as the functional roles of non-coding RNAs, have been identified as key factors in cancer, neurological disorders, and other diseases. This symposium will present recent findings on the molecular mechanisms and physiological functions of post-transcriptional regulation, discussing how its dysregulation contributes to disease onset and progression. Additionally, we will explore the potential of targeting RNA regulatory mechanisms for novel therapeutic strategies, aiming to deepen our understanding of RNA dysregulation in disease and its future applications in medicine.

【E】RNA Dysregulation and Disease Mechanisms

The 48th Annual Meeting of the Molecular Biology Society of Japan

Presentation Information

[2AS-07-04(2P-893)]PMR-116, a second generation ribosome biogenesis inhibitor

Password required to view

Comment